STARD4
StAR-related lipid transfer protein 4
Also known as: STAR4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96DR4
- Gene
- STARD4
- Ensembl
- ENSG00000164211
- Chromosome
- 5
- Canonical length
- 205 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Cholesterol homeostasis is regulated, at least in part, by sterol regulatory element (SRE)-binding proteins (e.g., SREBP1; MIM 184756) and by liver X receptors (e.g., LXRA; MIM 602423). Upon sterol depletion, LXRs are inactive and SREBPs are cleaved, after which they bind promoter SREs and activate genes involved in cholesterol biosynthesis and uptake. Sterol transport is mediated by vesicles or by soluble protein carriers, such as steroidogenic acute regulatory protein (STAR; MIM 600617). STAR is homologous to a family of proteins containing a 200- to 210-amino acid STAR-related lipid transfer (START) domain, including STARD4 (Soccio et al., 2002 [PubMed 12011452]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>Q96DR4|STARD4
1 MEGLSDVASF ATKLKNTLIQ YHSIEEDKWR VAKKTKDVTV WRKPSEEFNG YLYKAQGVID
61 DLVYSIIDHI RPGPCRLDWD SLMTSLDILE NFEENCCVMR YTTAGQLWNI ISPREFVDFS
121 YTVGYKEGLL SCGISLDWDE KRPEFVRGYN HPCGWFCVPL KDNPNQSLLT GYIQTDLRGM
181 IPQSAVDTAM ASTLTNFYGD LRKALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STARD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 38 nTPM
- small intestine: 34 nTPM
- liver: 32 nTPM
- placenta: 26 nTPM
- prostate: 19 nTPM
- cerebral cortex: 19 nTPM
Single-cell type
- monocytes: 65 nCPM
- mast cells: 54 nCPM
- alveolar cells type 2: 54 nCPM
- parietal cells: 51 nCPM
- retinal ganglion cells: 50 nCPM
- monocyte progenitors: 49 nCPM
Immune cell
- basophil: 7.2 nTPM
- gdT-cell: 2.5 nTPM
- intermediate monocyte: 2.1 nTPM
- NK-cell: 2.1 nTPM
- memory CD8 T-cell: 1.9 nTPM
- naive CD8 T-cell: 1.9 nTPM
Brain region
- cerebellum: 56 nTPM
- midbrain: 39 nTPM
- medulla oblongata: 38 nTPM
- basal ganglia: 36 nTPM
- thalamus: 35 nTPM
- pons: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol import
- intracellular cholesterol transport
- positive regulation of bile acid biosynthetic process
- positive regulation of cholesterol metabolic process
- cholesterol transport involved in cholesterol storage
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- START domain
- START-like domain superfamily
- START domain
- StAR-related lipid transfer protein 4
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STARD4 as an antibody target. Whether an autoantibody or antibody against STARD4 could matter depends on whether native STARD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STARD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STARD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...